Cardinal Health, Inc. (CAH) Fair Value 2026

CAH · Medical Distribution ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.9 /10

32 fundamental signals · 10 models active

Value Trap Risk

SAFE (12/100)

Quick Summary — As of 2026-10-07, Cardinal Health, Inc. (CAH) trades at $233.44, versus a $266.76 median fair value across its 10 active models — 14.3% above the current price. QOC: 7.9/10. Value Trap Risk: 12/100 (SAFE). 10/13 models active. Within that set, the Bayesian DCF component alone returns $378.04.

Key Facts

Ticker
CAH
Price
$233.44
Quality Score
7.9/10
Value Trap Risk
12/100
Models Active
10/13
Last Updated
Strength: First Chicago suggests +112.9% upside with 64% confidence
Risk: Limited model coverage (10/13) may reduce confidence

Is Cardinal Health, Inc. (CAH) Undervalued or Overvalued in 2026?

According to CirclFi’s 10-model valuation engine, Cardinal Health, Inc. (CAH) appears undervalued as of : the median of 10 independent fair value estimates is $266.76, 14.3% above the current price of $233.44. Estimates range from $58.79 to $522.91. CAH scores 7.9/10 on fundamental quality and 12/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -20.1% versus its own 13-model consensus, across 3,777 rated companies as of 2026-10-07. CAH’s +14.3% gap is narrower than that market norm. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Cardinal Health, Inc. Stock in 2026? →

What Fair Value Does Each Model Give CAH?

10 Intrinsic Value Models vs. Current Price ($233.44)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $378.04 +61.9%
Ensemble · Low Conviction
 $262.59 +12.5%
Scenario · High Conviction
 $496.97 +112.9%
Intrinsic · High Conviction
 $104.88 -55.1%
Unlock the Full Matrix

Access 6 additional models including EROIC Spread, Dynamic NAV, and more.

$2 / day

Billed monthly ($60/mo) or annually ($299/yr)

Unlock All 10 Models →

Cancel anytime · No contracts · Instant access

What Is CAH's Fair Value Range?

Spread across 10 independent models · $58.79 to $522.91

CirclFi's 10 active models place Cardinal Health, Inc. (CAH) between $58.79 and $522.91 per share, a spread of 174% of the median. The median of that range — $266.76 — is the fair value CirclFi publishes for CAH, against a current price of $233.44.

Low · EROICHigh · Regime Cross
$58.79median $266.76$522.91
Where the range comes from
Most bearish modelEROIC Spread$58.79
Most bullish modelRegime Cross-Sectional$522.91
Model agreement6 bullish · 4 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for CAH. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on CAH, not a CirclFi price target. How each model works →

What Is Cardinal Health, Inc. (CAH) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, our multi-model framework produces a cautiously optimistic read on Cardinal Health, Inc. at $233.44. With an estimated intrinsic value of $266.76 and 6 of 10 models pointing higher, the median implied return is +14.3%. The most optimistic model, Regime Cross, places fair value at $522.91 (+124.0%), while EROIC — the most conservative — estimates $58.79 (-74.8%). This +198.8% gap reflects genuine analytical uncertainty about Cardinal Health, Inc.'s intrinsic worth. Among models with highest confidence, Bayesian DCF lean bullish — adding weight to the bullish side of the thesis.

What Do the Models Say About CAH?

10 of 13 models are currently active for CAH. Of these, 6 models suggest upside while 4 models suggest overvaluation. Taken together, their median fair value for CAH is $266.76 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $378.04 on its own, implying +61.9% upside from the current price. See which stocks rank higher →

How Does CAH Rank in Medical Distribution?

Among 12 Medical Distribution stocks, CAH ranks #3 by Quality of Company score. CirclFi's QOC score of 7.9/10 evaluates 32 fundamental signals. A score of 7.9 indicates above-average quality.

Cardinal Health, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is CAH a Value Trap?

CirclFi's Value Trap algorithm assigns CAH a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

10 of 13 models are active for Cardinal Health, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Cardinal Health, Inc. scores 7.9 out of 10 on our 32-signal quality assessment, a strong rating that demonstrates strong fundamentals across the majority of our quality signals. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +198.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CAH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across CAH's 10 active models, average confidence is 51%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Cardinal Health, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Distribution Stocks Should You Also Analyze?

11 related Medical Distribution stocks with 13-model coverage

MCKMcKesson CorporationQOC 8.7CORCencora, Inc.QOC 8.3HSICHenry Schein, Inc.QOC 7.3YI111, Inc.QOC 6.8FOCLEDAP TMS S.A.QOC 5.8ACHAccendra Health, Inc.QOC 5.7VNOVVNOVQOC 5.6COSMCosmos Health Inc.QOC 4.6MEDSDataMEDS AI, Inc.QOC 4.2HKPDCellyan Biotechnology Co., LtdQOC 2.5AHGAkso Health GroupQOC 2.2

Read investment analysis: MCK · COR · HSIC · YI · FOCL · ACH · VNOV · COSM · MEDS · HKPD · AHG

Which Other Stocks Have a Similar Quality Score to CAH?

7 companies across all industries closest to CAH’s Quality of Company score of 7.9/10.

MDPediatrix Medical Group, Inc.QOC 7.9BBARBanco BBVA Argentina S.A.QOC 7.9AUBAtlantic Union Bankshares CorporationQOC 7.9EBMTEagle Bancorp Montana, Inc.QOC 7.9RPDRapid7, Inc.QOC 7.9FITBFifth Third BancorpQOC 7.9NVDANVIDIA CorporationQOC 10.0

Read investment analysis: MD · BBAR · AUB · EBMT · RPD · FITB · NVDA

What Else Do Investors Ask About Cardinal Health, Inc.’s Valuation?

What is Cardinal Health, Inc.'s intrinsic value in 2026?

CirclFi puts Cardinal Health, Inc. (CAH)'s intrinsic value at $266.76 — the median of 10 independent model estimates as of 2026-10-07, ranging from $58.79 to $522.91. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $378.04 on its own. The Quality of Company score is 7.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CAH overvalued or undervalued right now?

At $233.44, 6 of 10 active models suggest CAH may be undervalued, while 4 indicate potential overvaluation. The median of all 10 fair value estimates is $266.76, 14.3% above the current price of $233.44 — a consensus view that CAH is undervalued. The assessment depends on which methodology best fits Cardinal Health, Inc.'s business model in Medical Distribution.

What does a Quality of Company score of 7.9 mean for CAH?

Cardinal Health, Inc.'s QOC of 7.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on CAH?

CirclFi analyzes CAH with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 10 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on CAH?

Of the 10 models currently active on CAH, Regime Cross-Sectional is the most bullish at $522.91 per share, and EROIC Spread is the most bearish at $58.79. CirclFi's published fair value for CAH is the median of that range, $266.76, not either extreme. The gap between the two ends equals 174% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is CAH a value trap in 2026?

Cardinal Health, Inc.'s Value Trap score is 12/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 10-model valuation engine, Cardinal Health, Inc. (CAH) has a median fair value of $266.76 — 14.3% above the current price of $233.44 — as of 2026-10-07.” Source: circlfi.com/stock/CAH/ · Methodology
Primary sources for this CAH valuation
  • Financial statements: Cardinal Health, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000721371) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CAH as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 10 mathematical frameworks give you clarity on CAH.

Unlock All 10 Fair Values — $60/mo

Cancel anytime · Less than a cup of coffee · Instant access

6 models hidden for CAH Unlock All 10 — $60/mo